Neutral
Here’s how China could retaliate against U.S. tariffs
China is the world’s second-largest economy and second-largest importer of U.S. goods. Entities in China hold at least $784 billion in U.S. federal debt. The country also controls much of the world’s rare element supply, which is vital for manufacturing technology. China could weaponize these assets if an all-out trade war breaks out, to the […]
Read More
Booking Holdings CEO on travel demand: At the end of the day people will always want to travel
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Glenn Fogel, Booking Holdings CEO, joins ‘Squawk Box’ to discuss the company’s quarterly earnings results, state of travel demand, impact of policy uncertainty, utilizing AI for travel, and more. Source
Read More
Dubai Airports CEO talks about prioritizing speed & tech upgrades
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dubai International’s DXB has cemented its place as the busiest airport in the world. CEO Paul Griffiths talks about managing that traffic, and his outlook on cargo & passenger volume in light of trade and recession concerns. Source
Read More
Grab CFO: See greater growth and profitability in ‘underpenetrated’ Indonesia
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Grab’s CFO Peter Oey discusses why Indonesia remains a strategic priority for the business, emphasising a stronger focus on affordability and driver recruitment. Source
Read More
Genomics explained: How tech revealed the information inside our DNA
New technological advancements have allowed scientists to look at the entire human genome. But what are genomics, and why is it relevant? New technological advancements have allowed us to look at the entire human genome. The genome is the complete set of genetic information encoded in the DNA. Human DNA has around three billion letters […]
Read More
U.S. Travel Association CEO Geoff Freeman on the impact of tariffs on U.S. tourism
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Geoff Freeman, U.S. Travel Association president and CEO, joins ‘Squawk Box’ to discuss the impact of tariffs on the travel industry, declines in visits to the U.S., and more. Source
Read More
Ascott plans to double India portfolio, says limited supply provides room for growth
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Lee Ngor Houai, Ascott COO for EMEA, South Asia, and China, discusses the company’s plan to expand its portfolio in India to 12,000 units by 2028, with limited supply providing ample room for growth. He remains optimistic about India’s growth prospects, driven […]
Read More
We are still short on planes and engines, says Korean Air Chairman
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Korean Air CEO and Chairman, Walter Cho, discusses airline’s supply chain shortages, navigating Trump’s tariff issues and its merger with Asiana Airlines. Source
Read More
Travel + Leisure CEO: Didn’t see travel impacted in Q1 despite poor economic sentiment
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Mike Brown, Travel + Leisure president and CEO, joins ‘The Exchange’ to discuss the recent drama in the travel sector, if visitors from other countries are still visiting the U.S., and much more. Source
Read More
How Takeda’s CEO transformed the company into a global pharma powerhouse
Takeda Pharmaceuticals, Japan’s largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, emerging as one of the world’s leading pharmaceutical companies. Takeda Pharmaceuticals, Japan’s largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, emerging as one of the world’s leading pharmaceutical companies. The company’s $62 billion acquisition of U.K.-based Shire Pharmaceuticals […]
Read More